Faeth Therapeutics, Inc. Gain (Loss) on Disposition of Assets
Faeth Therapeutics, Inc. (FTH) reported Gain (Loss) on Disposition of Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-04
- Faeth Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2026-06-30 was $0.00.
- Faeth Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Faeth Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was -$1.00K.
- Faeth Therapeutics, Inc. gain (loss) on disposition of assets for the quarter ending 2025-06-30 was -$40.00K.
- Faeth Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2023 was -$302.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | |||
| 2025-09-30 | -$1.00K 10-Q · filed 2025-11-14 | -$41.00K derived: sum of 2 quarters · filed 2025-11-14 | -$21.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$40.00K 10-Q · filed 2025-08-05 | -$20.00K 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | $20.00K 10-Q · filed 2026-05-15 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$6.00K derived: sum of 2 quarters · filed 2025-03-28 | -$197.00K derived: sum of 3 quarters · filed 2025-03-28 | -$302.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$6.00K 10-Q · filed 2024-11-14 | -$197.00K derived: sum of 2 quarters · filed 2024-11-14 | -$302.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$191.00K 10-Q · filed 2024-08-06 | -$296.00K 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | -$105.00K 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |